Swords, Ireland
Merck will begin construction in the third quarter of 2018 on a biologics facility in County Dublin, Ireland. Located on Merck's 33-acre campus in Swords, the project includes the renovation and expansion of an existing 341,000-sf structure to create a 470,000-sf facility offering laboratory, production, and warehouse space. The state-of-the-art pharmaceutical plant will manufacture protein therapeutics derived from mammalian cell cultures. Occupancy is expected in 2021.
Source
